Cargando…

Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group

BACKGROUND: Our objective was to determine whether anti-interleukin (IL)-6 receptors improve outcomes of critically ill patients with coronavirus disease 2019 (COVID-19) pneumonia. We report on two cohort-embedded, investigator-initiated, multicentre, open-label, Bayesian randomised controlled clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermine, Olivier, Mariette, Xavier, Porcher, Raphael, Resche-Rigon, Matthieu, Tharaux, Pierre-Louis, Ravaud, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819469/ https://www.ncbi.nlm.nih.gov/pubmed/35115337 http://dx.doi.org/10.1183/13993003.02523-2021

Ejemplares similares

Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
por: Porcher, Raphaël, et al.
Publicado: (2022)

Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
por: Hermine, Olivier, et al.
Publicado: (2022)

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
por: Lacombe, Karine, et al.
Publicado: (2023)

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial
Publicado: (2022)

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Publicado: (2021)

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Publicado: (2021)

Evaluating mortality in intensive care units: contribution of competing risks analyses
por: Resche-Rigon, Matthieu, et al.
Publicado: (2006)

Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial
por: Lemiale, Virginie, et al.
Publicado: (2014)

Evaluation of the Propensity score methods for estimating marginal odds ratios in case of small sample size
por: Pirracchio, Romain, et al.
Publicado: (2012)

Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort
por: Tran, Viet-Thi, et al.
Publicado: (2022)

Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onset
por: Servier, Clemence, et al.
Publicado: (2023)

Do simple screening statistical tools help to detect reporting bias?
por: Pirracchio, Romain, et al.
Publicado: (2013)

Simple screening statistical tools to detect reporting bias: when should we ask for raw data?
por: Pirracchio, Romain, et al.
Publicado: (2013)

Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS
por: Legriel, Stephane, et al.
Publicado: (2016)

Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors
por: Galimard, Jacques-Emmanuel, et al.
Publicado: (2018)

Blockchain protocols in clinical trials: Transparency and traceability of consent
por: Benchoufi, Mehdi, et al.
Publicado: (2018)

Combining multiple imputation and meta-analysis with individual participant data
por: Burgess, Stephen, et al.
Publicado: (2013)

Methodological management of end-of-life decision data in intensive care studies: A systematic review of 178 randomized control trials published in seven major journals
por: Kerever, Sébastien, et al.
Publicado: (2019)

Complex systems approach to scientific publication and peer-review system: development of an agent-based model calibrated with empirical journal data
por: Kovanis, Michail, et al.
Publicado: (2015)

Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials
por: Atal, Ignacio, et al.
Publicado: (2015)

The Global Burden of Journal Peer Review in the Biomedical Literature: Strong Imbalance in the Collective Enterprise
por: Kovanis, Michail, et al.
Publicado: (2016)

Evaluating alternative systems of peer review: a large-scale agent-based modelling approach to scientific publication
por: Kovanis, Michail, et al.
Publicado: (2017)

Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study
por: Legrand, Matthieu, et al.
Publicado: (2022)

Multiple imputation for cause-specific Cox models: Assessing methods for estimation and prediction
por: Bonneville, Edouard F, et al.
Publicado: (2022)

High Burden of Non-Influenza Viruses in Influenza-Like Illness in the Early Weeks of H1N1v Epidemic in France
por: Schnepf, Nathalie, et al.
Publicado: (2011)

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Extensions of the probabilistic ranking metrics of competing treatments in network meta‐analysis to reflect clinically important relative differences on many outcomes
por: Mavridis, Dimitris, et al.
Publicado: (2019)

Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19
por: Dimosiari, Athina, et al.
Publicado: (2023)

Cardiac sarcoidosis: A long term follow up study
por: Cacoub, Patrice, et al.
Publicado: (2020)

Is thenar tissue hemoglobin oxygen saturation in septic shock related to macrohemodynamic variables and outcome?
por: Payen, Didier, et al.
Publicado: (2009)

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis
Publicado: (2015)

Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol
por: Azabou, Eric, et al.
Publicado: (2020)

Impact of the Nutri-Score front-of-pack nutrition label on purchasing intentions of individuals with chronic diseases: results of a randomised trial
por: Egnell, Manon, et al.
Publicado: (2022)

Prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis of non-pharmacological interventions
por: Hariri, Geoffroy, et al.
Publicado: (2023)

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)
por: Maslennikov, Roman, et al.
Publicado: (2021)

The REMDACTA trial: do interleukin receptor antagonists provide additional benefit in COVID-19?
por: Tatham, Kate C., et al.
Publicado: (2021)

Immune interventions in COVID-19: a matter of time?
por: Plaçais, Léo, et al.
Publicado: (2022)

Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial
por: Barnes, Caroline, et al.
Publicado: (2015)

Avoidable waste of research related to inadequate methods in clinical trials
por: Yordanov, Youri, et al.
Publicado: (2015)

Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries
por: Atal, Ignacio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1na7vtpndg6k87e46eg4k0u7ao